BIO VIEW (Israel) Financials

We suggest to use BIO VIEW fundamental analysis to find out if markets are today mispricing the company. Put another way you can use it to find out if BIO VIEW is indeed mispriced or if you can make any profits on it by purchasing it and then waiting for the market to recognize its mistake and reprise the security. We were able to interpolate thirty available fundamental indicators for BIO VIEW, which can be compared to its rivals. To ensure the equity is not overpriced, please confirm all BIO VIEW financials, including its price to book, revenue, ebitda, as well as the relationship between the price to sales and gross profit .
With this module, you can analyze BIO VIEW financials for your investing period. You should be able to track the changes in BIO VIEW individual financial statements over time to develop the understanding of its risk, liquidity, profitability, or other critical and vital indicators.
Understanding current and past BIO VIEW Financials, including the trends in assets, liabilities, equity and income are directly related to making proper and timely investing decisions. All of BIO VIEW's financial statements are interrelated, with each one affecting the others. For example, an increase in BIO VIEW's assets may result in an increase in income on the income statement.
Chance Of Financial Distress
Less than 50
BIO VIEW has    50 (%) percent chance of experiencing financial distress in the next two years of operations. The calculation of odds of distress for BIO VIEW stock is tightly coupled with the Probability of Bankruptcy. It complements the equity performance score by supplying investors with insight into company financials without requiring them to know too much about all of the complex accounting and financial indicators surrounding the entity. More Info
The data published in BIO VIEW's official financial statements usually reflect BIO VIEW's business processes, product offerings, services, and other fundamental events. But there are other numbers, ratios, or fundamental indicators derived from these statements that are easier to understand and visualize within the underlying realities that drive quantitative information of BIO VIEW. For example, before you start analyzing numbers published by BIO VIEW accountants, it's critical to develop an understanding of what BIO VIEW's liquidity, profitability, and earnings quality are in the context of the Healthcare space in which it operates.
Please note, the presentation of BIO VIEW's financial position, as portrayed in its financial statements, is often influenced by management's estimates, judgments, and sometimes even manipulations. In the best case, BIO VIEW's management is honest, while the outside auditors are strict and uncompromising. Whatever the case, the imprecision that can be found in BIO VIEW's accounting process means that the reasonable investor should take a skeptical approach toward the financial statement analysis of BIO VIEW. Please utilize our Beneish M Score to check the likelihood of BIO VIEW's management to manipulate its earnings.

BIO VIEW Company Summary

BIO VIEW competes with ISROTEL, POLYRAM PLASTIC, MAGIC SOFTWARE, E SCHNAPP, and REKAH PHARMA. BioView Ltd. develops, manufactures, and markets automated cell imaging and analysis solutions for use in cytology, cytogenetic, and pathology clinical and research laboratories in Israel and internationally. The company was founded in 2000 and is headquartered in Rehovot, Israel. BIO VIEW is traded on Tel Aviv Stock Exchange in Israel.
InstrumentIsrael Stock View All
ExchangeTel Aviv Stock Exchange
Business Address3 Pekeris Street
IndustryMedical Devices
Phone972 73 227 1025
CurrencyILS - Israeli Shekel
You should never invest in BIO VIEW without having analyzed its financial statements. Do not rely on someone else's analysis or guesses about the future performance of BIO VIEW Stock, because this is throwing your money away. Analyzing the key information contained in BIO VIEW's financial statements can give you an edge over other investors and help to ensure that your investments perform well for you.

BIO VIEW Key Financial Ratios

Generally speaking, BIO VIEW's financial ratios allow both analysts and investors to convert raw data from BIO VIEW's financial statements into concise, actionable information that can be used to evaluate the performance of BIO VIEW over time and compare it to other companies across industries. There are many critical financial ratios that investors are exposed to on a daily basis, but they are usually grouped into few meaningful categories from each financial statement that BIO VIEW reports annually and quarterly.

BIO VIEW Financial Ratios Relationships

Comparative valuation techniques use various fundamental indicators to help in determining BIO VIEW's current stock value. Our valuation model uses many indicators to compare BIO VIEW value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across BIO VIEW competition to find correlations between indicators driving BIO VIEW's intrinsic value. More Info.
BIO VIEW is number one stock in cash flow from operations category among related companies. It is number one stock in price to book category among related companies . The ratio of Cash Flow from Operations to Price to Book for BIO VIEW is about  4,376 . Comparative valuation analysis is a catch-all model that can be used if you cannot value BIO VIEW by discounting back its dividends or cash flows. This model doesn't attempt to find an intrinsic value for BIO VIEW's Stock . Still, instead, it compares the stock's price multiples to a benchmark or nearest competition to determine if the stock is relatively undervalued or overvalued. The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the BIO VIEW's earnings, one of the primary drivers of an investment's value.
Check out Trending Equities. You can also try Probability Of Bankruptcy module to get analysis of equity chance of financial distress in the next 2 years.

Other Tools for BIO VIEW Stock

When running BIO VIEW price analysis, check to measure BIO VIEW's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy BIO VIEW is operating at the current time. Most of BIO VIEW's value examination focuses on studying past and present price action to predict the probability of BIO VIEW's future price movements. You can analyze the entity against its peers and financial market as a whole to determine factors that move BIO VIEW's price. Additionally, you may evaluate how the addition of BIO VIEW to your portfolios can decrease your overall portfolio volatility.
Portfolio Comparator
Compare the composition, asset allocations and performance of any two portfolios in your account
Analyst Recommendations
Analyst recommendations and target price estimates broken down by several categories
Global Markets Map
Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes
Equity Forecasting
Use basic forecasting models to generate price predictions and determine price momentum
Transaction History
View history of all your transactions and understand their impact on performance
Cryptocurrency Center
Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency
Portfolio Anywhere
Track or share privately all of your investments from the convenience of any device
Crypto Correlations
Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins